11q21.1-11q23.3 is a site of intrinsic genomic instability triggered by irradiation

Genes Chromosomes and Cancer

Volumn 49, Issue 9, 2010, Pages 831-843

  Du, Nga ^a,b   Baker, Pamela M ^a,b   Do, To Uyen ^a,b   Bien, Christine ^c   Bier Laning, Carol M ^c   Singh, Sheetal ^a,b   Shih, Shyh Jen ^a,b   Diaz, Manual O ^c   Vaughan, Andrew T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; FLUORESCENT DYE; DNA; MICROSATELLITE DNA; PRIMER DNA;

ARTICLE; CELL SPECIFICITY; CHROMOSOME 11Q; CHROMOSOME DELETION; CHROMOSOME MAP; CONTROLLED STUDY; GENE DELETION; GENE INDUCTION; GENE ISOLATION; GENETIC ANALYSIS; GENETIC RECOMBINATION; GENETIC SCREENING; GENOME ANALYSIS; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IRRADIATION; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MOLECULAR CLONING; MUCOEPIDERMOID TUMOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE; CHEMISTRY; CHROMOSOME 11; DNA MICROARRAY; DRUG SCREENING; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; POLYMERASE CHAIN REACTION; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; DNA PRIMERS; DNA, NEOPLASM; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 77955496826     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20791     Document Type: Article

References (46)

1. Achcar Rde O, Nikiforova MN, Dacic S, Nicholson AG, Yousem SA. 2009. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol 40:854-860.
2. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen SM, Launonen V, Winqvist R. 2002. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: Indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 34:384-389. (Pubitemid 34787459)
3. Bell D, Luna MA, Weber RS, Kaye FJ, El-Naggar AK. 2008. CRTC1/MAML2 fusion transcript in Warthin's tumor and mucoepidermoid carcinoma: Evidence for a common genetic association. Genes Chromosomes Cancer 47:309-314.
4. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257.
5. Boyd M, Livingstone A, Wilson LE, Marshall EM, McCluskey AG, Mairs RJ, Wheldon TE. 2000. Dose-response relationship for radiation-induced mutations at micro- and minisatellite loci in human somatic cells in culture. Int J Radiat Biol 76:169-176. (Pubitemid 30093464)
6. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. 2003. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 63:1727-1730.
7. Brock GJ, Anderson NH, Monckton DG. 1999. Cis-acting modifiers of expanded CAG/CTG triplet repeat expandability: Associations with flanking GC content and proximity to CpG islands. Hum Mol Genet 8:1061-1067.
8. Conrad DF, Andrews TD, Carter NP, Hurles ME, Pritchard JK. 2006. A high-resolution survey of deletion polymorphism in the human genome. Nat Genet 38:75-81.
9. Edelbrock MA, Kaliyaperumal S, Williams KJ. 2009. DNA mismatch repair efficiency and fidelity are elevated during DNA synthesis in human cells. Mutat Res 662:59-66.
10. Fehr A, Meyer A, Heidorn K, Roser K, Loning T, Bullerdiek J. 2009. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Genes Chromosomes Cancer 48:777-785.
11. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. 2004. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res 64:7231-7236. (Pubitemid 39372057)
12. Goto A, Niki T, Chi-Pin L, Matsubara D, Murakami Y, Funata N, Fukayama M. 2005. Loss of TSLC1 expression in lung adenocarcinoma: Relationships with histological subtypes, sex and prognostic significance. Cancer Sci 96:480-486.
13. Grossman SR. 2001. p300/CBP/p53 interaction and regulation of the p53 response. Eur J Biochem 268:2773-2778.
14. Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kawata S, Kimura W, Nishizuka S, Murakami Y. 2002. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 93:857-860. (Pubitemid 35012245)
15. Hong Z, Jiang J, Hashiguchi K, Hoshi M, Lan L, Yasui A. 2008. Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J Cell Sci 121:3146-3154.
16. Houshmandi SS, Surace EI, Zhang HB, Fuller GN, Gutmann DH. 2006. Tumor suppressor in lung cancer-1 (TSLC1) functions as a glioma tumor suppressor. Neurology 67:1863-1866.
17. Ionov Y, Matsui S, Cowell JK. 2004. A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability. Proc Natl Acad Sci USA 101:1273-1278.
18. Kegel P, Riballo E, Kuhne M, Jeggo PA, Lobrich M. 2007. X-irradiation of cells on glass slides has a dose doubling impact. DNA Repair (Amst) 6:1692-1697.
19. Kimmel RR, Agnani S, Yang Y, Jordan R, Schwartz JL. 2008. DNA copy-number instability in low-dose γ-irradiated TK6 lymphoblastoid clones. Radiat Res 169:259-269. (Pubitemid 351521761)
20. Kong A, Gudbjartsson DF, Sainz J, Jonsdottir GM, Gudjonsson SA, Richardsson B, Sigurdardottir S, Barnard J, Hallbeck B, Masson G, Shlien A, Palsson ST, Frigge ML, Thorgeirsson TE, Gulcher JR, Stefansson K. 2002. A high-resolution recombination map of the human genome. Nat Genet 31:241-247.
21. Kovtun IV, McMurray CT. 2008. Features of trinucleotide repeat instability in vivo. Cell Res 18:198-213.
22. Kuhn RM, Karolchik D, Zweig AS, Wang T, Smith KE, Rosenbloom KR, Rhead B, Raney BJ, Pohl A, Pheasant M, Meyer L, Hsu F, Hinrichs AS, Harte RA, Giardine B, Fujita P, Diekhans M, Dreszer T, Clawson H, Barber GP, Haussler D, Kent WJ. 2009. The UCSC Genome Browser Database: Update 2009. Nucleic Acids Res 37:D755-D761.
23. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, Murakami Y. 2001. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 27:427-430.
24. Lai LA, Paulson TG, Li X, Sanchez CA, Maley C, Odze RD, Reid BJ, Rabinovitch PS. 2007. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 46:532-542.
25. Lasko D, Cavenee W, Nordenskjold M. 1991. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 25:281-314. (Pubitemid 21903723)
26. Lee AS, Seo YC, Chang A, Tohari S, Eu KW, Seow-Choen F, McGee JO. 2000. Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma. Br J Cancer 83:750-755.
27. Martin ES, Cesari R, Pentimalli F, Yoder K, Fishel R, Himelstein AL, Martin SE, Godwin AK, Negrini M, Croce CM. 2003. The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci USA 100:11517-11522.
28. Mohan RD, Litchfield DW, Torchia J, Tini M. 2010. Opposing regulatory roles of phosphorylation and acetylation in DNA mispair processing by thymine DNA glycosylase. Nucleic Acids Res 38:1135-1148.
29. Moynahan ME, Jasin M. 1997. Loss of heterozygosity induced by a chromosomal double-strand break. Proc Natl Acad Sci USA 94:8988-8993. (Pubitemid 27357769)
30. Nagahata T, Hirano A, Utada Y, Tsuchiya S, Takahashi K, Tada T, Makita M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M. 2002. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers. Breast Cancer 9:208-215.
31. Ogiwara H, Kohno T, Nakanishi H, Nagayama K, Sato M, Yokota J. 2008. Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer. Oncogene 27:4788-4797.
32. Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P. 2007. Genetic susceptibility for breast cancer: How many more genes to be found? Crit Rev Oncol Hematol 63:125-149.
33. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM. 2007. Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46:761-775.
34. Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, Trivett M, Thompson ER, Ramakrishna M, Gorringe KL, Polyak K, Haviv I, Campbell IG. 2008. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 40:650-655.
35. Rigat BA, Lorimore SA, Plumb MA, Wright EG. 2001. A PCRbased clonal analysis of radiation-induced loss of heterozygosity in haemopoietic stem cells. Leukemia 15:1604-1611.
36. Shiloh Y. 2003. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3:155-168. (Pubitemid 37328868)
37. Shimura T, Toyoshima M, Adiga SK, Kunoh T, Nagai H, Shimizu N, Inoue M, Niwa O. 2006. Suppression of replication fork progression in low-dose-specific p53-dependent S-phase DNA damage checkpoint. Oncogene 25:5921-5932.
38. Slaughter DP, Southwick HW, Smejkal W. 1953. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-968.
39. Stark JM, Jasin M. 2003. Extensive loss of heterozygosity is suppressed during homologous repair of chromosomal breaks. Mol Cell Biol 23:733-743. (Pubitemid 36050564)
40. Tan D, Wiseman S, Zhou Y, Li Q, Ward P, Slocum HK, Alrawi S, Loree T, Hicks W, Rigual N, Anderson G, Stoler D. 2004. Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique. Diagn Mol Pathol 13: 33-40.
41. Thompson LH, Schild D. 2002. Recombinational DNA repair and human disease. Mutat Res 509:49-78. (Pubitemid 35341453)
42. Tonon G, Gehlhaus KS, Yonescu R, Kaye FJ, Kirsch IR. 2004. Multiple reciprocal translocations in salivary gland mucoepidermoid carcinomas. Cancer Genet Cytogenet 152:15-22.
43. Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, Frebourg T, Iggo R. 1997. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene 14:163-169.
44. Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, Eng C. 2007. Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma. J Am Med Assoc 297:187-195.
45. Wu L, Liu J, Gao P, Nakamura M, Cao Y, Shen H, Griffin JD. 2005. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation. EMBO J 24:2391-2402. (Pubitemid 41032590)
46. Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS. 2005. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. Genes Chromosomes Cancer 43:95-103.